• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

早期慢性肾脏病(G1-G3a)合并脂肪变性作为缺血性心脏病发病的预测因素:一项针对非糖尿病韩国人的纵向研究。

Early Chronic Kidney Disease (G1-G3a) in Combination with Steatosis as a Predictor of Incident Ischemic Heart Disease: A Longitudinal Study in Non-Diabetic Koreans.

作者信息

Lee Sung-Bum, Park Byoung-Jin, Lee Yong-Jae, Jung Dong-Hyuk

机构信息

Department of Health Check-up, Yongin Severance Hospital, Yongin-si 16995, Korea.

Department of Family Medicine, Yongin Severance Hospital, Yongin-si 16995, Korea.

出版信息

Biomedicines. 2021 Sep 29;9(10):1358. doi: 10.3390/biomedicines9101358.

DOI:10.3390/biomedicines9101358
PMID:34680475
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8533481/
Abstract

Hepatic steatosis and chronic kidney disease (CKD) in the advanced stages are closely related to cardiovascular diseases. Despite the potential connection between early CKD (G1-G3a) and hepatic steatosis on cardiometabolic risks, few studies have revealed their causal link to ischemic heart disease (IHD). We prospectively investigated the combined effect of CKD in earlier stages and hepatic steatosis on incident IHD risk in large-scale, non-diabetic Koreans. Data were assessed from 16,531 participants without diabetes from the Health Risk Assessment Study (HERAS) and Korea Health Insurance Review and Assessment (HIRA) data. We divided the study population into four groups according to the existence of early CKD and hepatic steatosis: controls, early CKD only, hepatic steatosis only, and both early CKD and hepatic steatosis. We prospectively assessed hazard ratios (HRs) with 95% confidence intervals (CIs) for IHD using multivariate Cox proportional-hazard regression models over a 50-month period. During the follow-up period, 326 (2.0%) patients developed IHD. HRs of IHD in the four groups were 1.00 (controls), 1.26 (95% CI 0.72-2.19), 1.19 (95% CI 0.90-1.57) and 1.76 (95% CI 1.04-2.97), respectively, after adjusting for potential confounding variables. Even less than stage 3A, CKD could precede and predict IHD in patients with hepatic steatosis.

摘要

晚期肝脂肪变性和慢性肾脏病(CKD)与心血管疾病密切相关。尽管早期CKD(G1-G3a)与肝脂肪变性在心脏代谢风险方面存在潜在联系,但很少有研究揭示它们与缺血性心脏病(IHD)之间的因果关系。我们对大量非糖尿病韩国人群中早期CKD和肝脂肪变性对IHD发病风险的联合影响进行了前瞻性研究。数据来自健康风险评估研究(HERAS)和韩国健康保险审查与评估(HIRA)中16531名无糖尿病的参与者。我们根据早期CKD和肝脂肪变性的存在情况将研究人群分为四组:对照组、仅早期CKD组、仅肝脂肪变性组以及早期CKD和肝脂肪变性均有的组。我们使用多变量Cox比例风险回归模型在50个月的时间内前瞻性评估IHD的风险比(HRs)及95%置信区间(CIs)。在随访期间,326名(2.0%)患者发生了IHD。在调整潜在混杂变量后,四组IHD的HRs分别为1.00(对照组)、1.26(95%CI 0.72-2.19)、1.19(95%CI 0.90-1.57)和1.76(95%CI 1.04-2.97)。即使在3A期以下,CKD也可能先于并预测肝脂肪变性患者发生IHD。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b9f0/8533481/a58b07ecffa0/biomedicines-09-01358-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b9f0/8533481/a0e21c122ef5/biomedicines-09-01358-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b9f0/8533481/a58b07ecffa0/biomedicines-09-01358-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b9f0/8533481/a0e21c122ef5/biomedicines-09-01358-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b9f0/8533481/a58b07ecffa0/biomedicines-09-01358-g002.jpg

相似文献

1
Early Chronic Kidney Disease (G1-G3a) in Combination with Steatosis as a Predictor of Incident Ischemic Heart Disease: A Longitudinal Study in Non-Diabetic Koreans.早期慢性肾脏病(G1-G3a)合并脂肪变性作为缺血性心脏病发病的预测因素:一项针对非糖尿病韩国人的纵向研究。
Biomedicines. 2021 Sep 29;9(10):1358. doi: 10.3390/biomedicines9101358.
2
Joint Effect of Hepatic Steatosis and Alanine Aminotransferase Within the Normal Range on Incident Ischemic Heart Disease: A Prospective Study in Koreans.肝脂肪变和正常范围内的丙氨酸氨基转移酶联合对新发缺血性心脏病的影响:一项韩国前瞻性研究。
Clin Interv Aging. 2021 Mar 22;16:513-523. doi: 10.2147/CIA.S301741. eCollection 2021.
3
Elevated Uric Acid Levels with Early Chronic Kidney Disease as an Indicator of New-Onset Ischemic Heart Disease: A Cohort of Koreans without Diabetes.以早期慢性肾脏病高尿酸水平作为新发缺血性心脏病指标:一项针对无糖尿病韩国人群的队列研究
Biomedicines. 2023 Aug 7;11(8):2212. doi: 10.3390/biomedicines11082212.
4
Longitudinal Effect of Hemoglobin Concentration With Incident Ischemic Heart Disease According to Hepatic Steatosis Status Among Koreans.韩国人中心脏脂肪变性状态下血红蛋白浓度与缺血性心脏病发病的纵向效应
Front Cardiovasc Med. 2021 May 28;8:677040. doi: 10.3389/fcvm.2021.677040. eCollection 2021.
5
The Metabolic Score for Insulin Resistance (METS-IR) as a Predictor of Incident Ischemic Heart Disease: A Longitudinal Study among Korean without Diabetes.胰岛素抵抗代谢评分(METS-IR)作为缺血性心脏病发病的预测指标:一项针对无糖尿病韩国人的纵向研究。
J Pers Med. 2021 Jul 28;11(8):742. doi: 10.3390/jpm11080742.
6
Potential Association of Isolated γ-Glutamyltransferase Elevation with Incident Ischemic Heart Disease in Lean Koreans.韩国瘦人群体中孤立性γ-谷氨酰转移酶升高与缺血性心脏病发病之间的潜在关联
J Pers Med. 2022 Nov 28;12(12):1966. doi: 10.3390/jpm12121966.
7
Predictive Value of the Atherogenic Index of Plasma (AIP) for the Risk of Incident Ischemic Heart Disease among Non-Diabetic Koreans.血浆致动脉粥样硬化指数(AIP)对非糖尿病韩国人群新发缺血性心脏病风险的预测价值。
Nutrients. 2021 Sep 16;13(9):3231. doi: 10.3390/nu13093231.
8
The triglyceride-glucose index predicts ischemic heart disease risk in Koreans: a prospective study using National Health Insurance Service data.甘油三酯-葡萄糖指数预测韩国人缺血性心脏病风险:基于国民健康保险服务数据的前瞻性研究。
Cardiovasc Diabetol. 2020 Dec 10;19(1):210. doi: 10.1186/s12933-020-01186-2.
9
Triglyceride to HDL-Cholesterol Ratio and the Incident Risk of Ischemic Heart Disease Among Koreans Without Diabetes: A Longitudinal Study Using National Health Insurance Data.甘油三酯与高密度脂蛋白胆固醇比值及无糖尿病韩国人缺血性心脏病发病风险:一项利用国民健康保险数据的纵向研究
Front Cardiovasc Med. 2021 Aug 17;8:716698. doi: 10.3389/fcvm.2021.716698. eCollection 2021.
10
The Combination of Uric Acid and Hemoglobin Levels Predicts the Incident Risk of Ischemic Heart Disease More Than Uric Acid Alone in Non-Diabetic Koreans: A Longitudinal Study Using National Health Insurance Data.尿酸与血红蛋白水平联合预测非糖尿病韩国人缺血性心脏病发病风险优于单独尿酸:一项利用国民健康保险数据的纵向研究
J Pers Med. 2023 Dec 20;14(1):7. doi: 10.3390/jpm14010007.

引用本文的文献

1
The Combination of Uric Acid and Hemoglobin Levels Predicts the Incident Risk of Ischemic Heart Disease More Than Uric Acid Alone in Non-Diabetic Koreans: A Longitudinal Study Using National Health Insurance Data.尿酸与血红蛋白水平联合预测非糖尿病韩国人缺血性心脏病发病风险优于单独尿酸:一项利用国民健康保险数据的纵向研究
J Pers Med. 2023 Dec 20;14(1):7. doi: 10.3390/jpm14010007.
2
Elevated Uric Acid Levels with Early Chronic Kidney Disease as an Indicator of New-Onset Ischemic Heart Disease: A Cohort of Koreans without Diabetes.以早期慢性肾脏病高尿酸水平作为新发缺血性心脏病指标:一项针对无糖尿病韩国人群的队列研究
Biomedicines. 2023 Aug 7;11(8):2212. doi: 10.3390/biomedicines11082212.
3

本文引用的文献

1
Accuracy of the ultrasound attenuation coefficient for the evaluation of hepatic steatosis: a systematic review and meta-analysis of prospective studies.超声衰减系数评估肝脂肪变性的准确性:前瞻性研究的系统评价和荟萃分析
Ultrasonography. 2022 Jan;41(1):83-92. doi: 10.14366/usg.21076. Epub 2021 Jun 1.
2
Joint Effect of Hepatic Steatosis and Alanine Aminotransferase Within the Normal Range on Incident Ischemic Heart Disease: A Prospective Study in Koreans.肝脂肪变和正常范围内的丙氨酸氨基转移酶联合对新发缺血性心脏病的影响:一项韩国前瞻性研究。
Clin Interv Aging. 2021 Mar 22;16:513-523. doi: 10.2147/CIA.S301741. eCollection 2021.
3
Longitudinal Effects of Serum Calcium and Phosphate Levels and Their Ratio on Incident Ischemic Heart Disease among Korean Adults.
血清钙和磷水平及其比值对韩国成年人新发缺血性心脏病的纵向影响。
Biomolecules. 2022 Jan 8;12(1):103. doi: 10.3390/biom12010103.
A brief review on the rising incidence of chronic kidney diseases and non-alcoholic fatty liver disease.
慢性肾脏病和非酒精性脂肪性肝病发病率上升的简要综述。
Physiol Int. 2019 Dec 1;106(4):305-310.
4
Global burden of NAFLD and NASH: trends, predictions, risk factors and prevention.非酒精性脂肪性肝病和非酒精性脂肪性肝炎的全球负担:趋势、预测、危险因素和预防。
Nat Rev Gastroenterol Hepatol. 2018 Jan;15(1):11-20. doi: 10.1038/nrgastro.2017.109. Epub 2017 Sep 20.
5
Fatty Liver and Chronic Kidney Disease: Novel Mechanistic Insights and Therapeutic Opportunities.脂肪肝与慢性肾脏病:新的发病机制研究与治疗机会
Diabetes Care. 2016 Oct;39(10):1830-45. doi: 10.2337/dc15-1182.
6
New Pharmacologic Agents That Target Inflammation and Fibrosis in Nonalcoholic Steatohepatitis-Related Kidney Disease.针对非酒精性脂肪性肝炎相关肾病的炎症和纤维化的新型药物制剂。
Clin Gastroenterol Hepatol. 2017 Jul;15(7):972-985. doi: 10.1016/j.cgh.2016.08.002. Epub 2016 Aug 10.
7
Global Prevalence of Chronic Kidney Disease - A Systematic Review and Meta-Analysis.全球慢性肾脏病患病率——一项系统评价与荟萃分析
PLoS One. 2016 Jul 6;11(7):e0158765. doi: 10.1371/journal.pone.0158765. eCollection 2016.
8
High Blood Pressure and Its Association With Incident Diabetes Over 10 Years in the Korean Genome and Epidemiology Study (KoGES).韩国基因组与流行病学研究(KoGES)中 10 年内高血压与新发糖尿病的关系。
Diabetes Care. 2015 Jul;38(7):1333-8. doi: 10.2337/dc14-1931. Epub 2015 May 18.
9
Chronic kidney disease and cardiovascular complications.慢性肾脏病与心血管并发症
Heart Fail Rev. 2015 May;20(3):259-72. doi: 10.1007/s10741-014-9460-9.
10
Relationship between blood mercury concentrations and serum γ-glutamyltranspeptidase level in Korean adults using data from the 2010 Korean National Health and Nutrition Examination Survey.利用韩国 2010 年全国健康和营养调查的数据,研究韩国成年人血液汞浓度与血清 γ-谷氨酰转肽酶水平之间的关系。
Clin Chim Acta. 2014 Mar 20;430:160-3. doi: 10.1016/j.cca.2014.01.042. Epub 2014 Feb 7.